<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04808765</url>
  </required_header>
  <id_info>
    <org_study_id>ZG01012019</org_study_id>
    <nct_id>NCT04808765</nct_id>
  </id_info>
  <brief_title>Closed Incision Disposable Negative Pressure Wound Therapy in Immediate Postmastectomy Breast Reconstruction</brief_title>
  <official_title>Experience and Comparison Between Closed Incision Disposable Negative Pressure Wound Therapy With Standard Care in Immediate Postmastectomy Breast Reconstruction - Prospective, Randomized and Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University in Zielona Góra</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ConvaTec Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University in Zielona Góra</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aimed to assess the impact of the use of closed incision negative pressure wound&#xD;
      therapy (ciNPWT) after immediate breast reconstruction on the number of surgical-site&#xD;
      complications, skin surface temperature, objective elastic and viscoelastic and subjective&#xD;
      scar's quality to determine risk factors that could be considered as indications for&#xD;
      prophylactic ciNPWT application.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Breast cancer excluding skin cancer is the most commonly diagnosed cancer after lung cancer&#xD;
      among women. In recent years, the incidence rate of breast cancer has been rising by 0,3%&#xD;
      annually. Screening tests are designed to diagnose breast cancer in possible early stadium of&#xD;
      disease. Rapid diagnosis and efficacy of neoadjuvant and adjuvant therapies influence on&#xD;
      immediate breast reconstructions after skin (SSM) and nipple-sparing mastectomies (NSM). The&#xD;
      prophylactic methods of reducing a higher wound healing complication rate after neoadjuvant&#xD;
      and adjuvant therapies are crucial.&#xD;
&#xD;
      The study aimed to assess the impact of the use of closed incision negative pressure wound&#xD;
      therapy (ciNPWT) after immediate breast reconstruction on the number of surgical-site&#xD;
      complications, skin surface temperature, objective elastic and viscoelastic and subjective&#xD;
      scar's quality to determine risk factors that could be considered as indications for&#xD;
      prophylactic ciNPWT application.&#xD;
&#xD;
      The analysis included data from anamnesis, details of performed surgical procedure,&#xD;
      measurements of skin surface temperature with Skin-Thermometer® probe, measurements of skin&#xD;
      elasticity with Cutometer® probe, and scar assessments according to POSAS v2.0 questionnaire&#xD;
      for patient and observer.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Anticipated">July 1, 2021</completion_date>
  <primary_completion_date type="Actual">January 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postsurgical complications - reported for 60 patients</measure>
    <time_frame>1 month</time_frame>
    <description>surgical site complications</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postsurgical complications - reported for 60 patients</measure>
    <time_frame>1 year</time_frame>
    <description>surgical site complications</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Superficial Skin Temperature (SST) of scar, skin next to scar and the second breast</measure>
    <time_frame>1 week after surgery</time_frame>
    <description>measure SST with Skin-Thermometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Superficial Skin Temperature (SST) of scar, skin next to scar and the second breast</measure>
    <time_frame>1 month after surgery</time_frame>
    <description>measure SST with Skin-Thermometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Objective examination of scar quality</measure>
    <time_frame>1 year after surgery</time_frame>
    <description>measure skin elasticity with Cutometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective examination of scar quality</measure>
    <time_frame>1 year after surgery</time_frame>
    <description>POSAS 2.0 (Patient and Observer Scar Assessment Scale) questionnaire for the observer and the patient.&#xD;
Questions regards painful, itchy scar, difference between scar and normal skin. The min score is 7, the max score is 70. The higher score means better result</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective quality of life</measure>
    <time_frame>1-2 years after surgery</time_frame>
    <description>BREAST-Q reconstruction module and Breast implant illness survey for patients. Questions about self-confidence, comfort, acceptance of new appearance, feeling of implants, breast pain. The min score is 1, the max 3-5 depending on part of questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Breast Cancer</condition>
  <condition>Breast Reconstruction</condition>
  <arm_group>
    <arm_group_label>VAC group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A randomized group of patients receiving negative pressure wound therapy dressing (Avelle-ConvaTec) on closed incision</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ST group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A randomized group of patients receiving standard dressing (sterile gauze and medical tape) on closed incision</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Immediate Breast reconstruction</intervention_name>
    <description>immediate mastectomy with breast reconstruction with implants or expanders</description>
    <arm_group_label>ST group</arm_group_label>
    <arm_group_label>VAC group</arm_group_label>
    <other_name>immediate mastectomy with breast reconstruction with implants or expanders</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  &gt;= 18 years of age&#xD;
&#xD;
          -  indications for immediate breast reconstruction&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnancy or lactation,&#xD;
&#xD;
          -  use of steroids, use of immune modulators known to affect wound healing;&#xD;
&#xD;
          -  tattoos in the area of the incision;&#xD;
&#xD;
          -  breast skin conditions such as cutis laxa;&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>female patients with indications for immediate breast reconstruction</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dawid Murawa, PROF</last_name>
    <role>Study Chair</role>
    <affiliation>University in Zielona Gora</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University in Zielona Gora</name>
      <address>
        <city>Zielona Gora</city>
        <state>Lubuskie</state>
        <zip>65-046</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <results_reference>
    <citation>Singh D, Lobach V, Holton T. Use of Closed-Incision Negative-Pressure Therapy in Aesthetic Surgery. Plast Reconstr Surg. 2019 Jan;143(1S Management of Surgical Incisions Utilizing Closed-Incision Negative-Pressure Therapy):11S-14S. doi: 10.1097/PRS.0000000000005306. Review.</citation>
    <PMID>30586097</PMID>
  </results_reference>
  <results_reference>
    <citation>Willy C, Agarwal A, Andersen CA, Santis G, Gabriel A, Grauhan O, Guerra OM, Lipsky BA, Malas MB, Mathiesen LL, Singh DP, Reddy VS. Closed incision negative pressure therapy: international multidisciplinary consensus recommendations. Int Wound J. 2017 Apr;14(2):385-398. doi: 10.1111/iwj.12612. Epub 2016 May 12. Review.</citation>
    <PMID>27170231</PMID>
  </results_reference>
  <results_reference>
    <citation>Gabriel A, Sigalove SR, Maxwell GP. Initial Experience Using Closed Incision Negative Pressure Therapy after Immediate Postmastectomy Breast Reconstruction. Plast Reconstr Surg Glob Open. 2016 Jul 22;4(7):e819. doi: 10.1097/GOX.0000000000000803. eCollection 2016 Jul.</citation>
    <PMID>27536498</PMID>
  </results_reference>
  <results_reference>
    <citation>Gabriel A, Sigalove S, Sigalove N, Storm-Dickerson T, Rice J, Maxwell P, Griffin L. The Impact of Closed Incision Negative Pressure Therapy on Postoperative Breast Reconstruction Outcomes. Plast Reconstr Surg Glob Open. 2018 Aug 7;6(8):e1880. doi: 10.1097/GOX.0000000000001880. eCollection 2018 Aug.</citation>
    <PMID>30324063</PMID>
  </results_reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 17, 2021</study_first_submitted>
  <study_first_submitted_qc>March 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 22, 2021</study_first_posted>
  <last_update_submitted>March 21, 2021</last_update_submitted>
  <last_update_submitted_qc>March 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University in Zielona Góra</investigator_affiliation>
    <investigator_full_name>Karolina Pieszko</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>breast cancer</keyword>
  <keyword>closed incision negative pressure wound therapy</keyword>
  <keyword>Breast Reconstruction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Surgical Wound</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

